ABSTRACT
Botanical preparations for herbal medicine have received more and more attention from drug researchers, and the extraction of active ingredients and their successful clinical application have become an important direction of drug research in major pharmaceutical companies, but the complexity of extracts, multiple side effects, and significant individual differences have brought many difficulties to the clinical application of herbal preparations. It is noteworthy that extracellular vesicles as active biomolecules extracted from medicinal plants are believed to be useful for the treatment of a variety of diseases, including cancer, inflammation, regenerative-restorative and degenerative diseases, which may provide a new direction for the clinical utilization of herbal preparations. In this review, we sort out recent advances in medicinal plant extracellular vesicles and discuss their potential as disease therapeutics. Finally, future challenges and research directions for the clinical translation of medicinal plant extracellular vesicles are also discussed, and we expect that continued development based on medicinal plant extracellular vesicles will facilitate the clinical application of herbal preparations.
Subject(s)
Extracellular Vesicles , Plants, Medicinal , Animals , Humans , Extracellular Vesicles/chemistry , Neoplasms/drug therapy , Phytotherapy/methods , Plant Extracts/pharmacology , Plant Extracts/chemistry , Plants, Medicinal/chemistry , Plants, Medicinal/cytologyABSTRACT
Se postula y fundamenta Ia utilidad de una mezcIa de extractos de plantas medicinales con propiedades sinérgicas compuesta por Psidium guajava L. estandarizado en su contenido de heterósidos flavónicos y Coptis chinensis Franch., estandarizado en su contenido de aIcaIoides benzofenantridínicos, para eI desarroIIo de un fitomedicamento útiI para eI tratamiento y prevención de Ia gastritis crónica provocada por Helícobacter pylori. EI estudio explora eI potencial que tiene Ia mezcIa para inhibir eI crecimiento in vitro de diversas cepas clínicas de H. pylori resistentes a los antibióticos convencionales, así como, su acción protectora deI epiteIio gástrico, al impedir Ia adherencia de Ia bacteria alas celulas AGS en cultivo (AU)
Descreve-se e fundamenta-se a utilidade de uma associagáo de extratos de plantas medicinais com propriedades sinergicas composta por Psidium guajava L., extracto padronizado em glicósidos flavónicos e Coptis chinensis Franch, extracto padronizado em alcalóides benzofenantridínicos, para o desenvolvimento de um medicamento a base de plantas para o tratamento e prevençáo da gastrite crónica provocada por Helicobacter pylori. O estudo explora o potencial que tem esta associaçáo para inibir o crescimento in vitro de diversas estirpes clinicas de H. pylori resistentes aos antibióticos convencionais, assim como, a sua acçáo protectora do epitelio gástrico, ao impedir a aderencia das bacterias ás culturas celulares de AGS (AU)
It is described the synergistic properties of a mixture of Psidium guajava L., extract standardized in its content of flavone glycosides and Coptis chinensis Franch, extract standardized in its content of benzophenantridinic alkaloids, for developing a phytodrug for the treatment and prevention of chronic gastritis induced by Helicobacter pylori. The study explores the properties of this combination of extracts by inhibiting in vitro growth of antibiotic-resistant clinical H. pylori strains and preventing adherence of the bacteria to human AGS cell cultures (AU)
Subject(s)
Humans , Male , Female , Helicobacter pylori/classification , Helicobacter pylori/cytology , Plants, Medicinal/anatomy & histology , Plants, Medicinal/cytology , Gastritis/metabolism , In Vitro Techniques/methods , Anti-Bacterial Agents/analysis , Anti-Bacterial Agents/biosynthesis , Gastrointestinal Tract/pathology , Primary Cell Culture/methods , Helicobacter pylori/enzymology , Helicobacter pylori/growth & development , Plants, Medicinal/adverse effects , Plants, Medicinal/metabolism , Gastritis/classification , In Vitro Techniques , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/classification , Gastrointestinal Tract/abnormalities , Primary Cell CultureABSTRACT
El propósito del presente trabajo fue determinar la potencia antimicrobiana de extractos alcohólicos de plantas utilizadas popularmente en Argentina como antisépticos y antiinflamatorios: Dasyphyllum diaconthoides, Erythrina cristagalli, Larrea cuneifolia, Larrea divaricata, Phytolacca dioica, Pithecoctenium cynanchoides, Prosopanche americana, Schinus molle, Schkuhria pinnata, Senna aphylla y Solidago chilensis. La inhibición del crecimiento bacteriano se determinó a través de ensayos de difusión en agar, macrodilución en medio sólido y microdilución en medio líquido frente a 47 aislamientos clínicos multirresistentes a antibióticos, obtenidos de pacientes de un hospital de Tucumán, Argentina: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae, Serratia marcescens, Morganella morganii, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia. De acuerdo con los valores de concentración inhibitoria mínima (CIM), tres de las once especies ensayadas fueron las más activas: L. divaricata, L. cuneifolia, y S. aphylla (CIM de 25 a 200 µg/mL). P. mirabilis, A. baumanni y S. maltophilia fueron las cepas más susceptibles con valores de CIM entre 25 y 50 µg/mL seguido por P. aeruginosa con valores de CIM de 50 a 100 µg/mL. Los valores de concentración bactericida mínima (CBM) fueron semejantes o dos veces superiores a los valores de CIM. Mediante ensayos bioautográficos se comprobó que los extractos más activos presentaban al menos dos principios antimicrobianos. Análisis fitoquímicos indican que estos compuestos son de naturaleza fenólica. Los resultados obtenidos justificarían el uso de estos extractos para el tratamiento de infecciones bacterianas, especialmente aquellas de origen dérmico.
The present study was conducted to investigate antimicrobial activity of alcoholic extracts of Argentine medicinal plant species (Dasyphyllum diacanthoides, Erythrina cristagalli, Larrea cuneifolia, Larrea divaricata, Phytolacca dioica, Pithecoctenium cynanchoides, Prosopanche americana, Schinus molle, Schkuhria pinnata, Senna aphylla and Solidago chilensis) against multidrug resistant human pathogen gram negative bacteria isolated from a Hospital in Tucumán, Argentina. Inhibition of bacterial growth was investigated using disc diffusion, agar macrodilution and broth microdilution methods against multiresistant clinical isolates of nine different specie of gram negative bacteria: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae, Serratia marcescens, Morganella morganii, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia. A significant antimicrobial activity was found in three of the eleven plant species studied. Based on minimal inhibitory concentration (MIC) values, three plant species, L. divaricata, L. cuneifolia, and S. aphylla were the most potent ones with MIC values between 25-200 µg/mL. Overall, P. mirabilis, M. morganii and P. aeruginosa isolates were the most susceptible to these extracts with MIC values of 25 to 50 µg/mL. All extracts showed significant inhibitory activities on bacteria growth in a dose phenolic compound-dependent fashion. The minimal bactericidal concentration (MBC) values were identical to the MIC values or twofold higher than the corresponding MIC. Contact bioautography indicated that crude extracts possess several major antibacterial components. Phytochemical screening showed that the bioactive compounds correspond to polyphenols. Investigations are in progress to purify the bioactive principles.
Subject(s)
Plants, Medicinal , Plants, Medicinal/physiology , Plants, Medicinal/microbiology , Argentina , Plants, Medicinal/cytology , Drug Resistance, Microbial , Schinus molle , Larrea , Erythrina , Anti-Infective AgentsABSTRACT
The carbohydrate-binding specificity of lectins from the seeds of Canavalia maritima and Dioclea grandiflora was studied by hapten-inhibition of haemagglutination using various sugars and sugar derivatives as inhibitors, including N-acetylneuraminic acid and N-acetylneuraminic acid and N-acetylmuramic acid. Despite some discrepancies, both lectins exhibited a very similiar carbohydrate-binding specificity as previously reported for other lectins from Diocleinae (tribe Phaseoleae, sub-tribe Diocleinae). Accordingly, both lectins exhibited almost identical hydropathic profiles and their three-dimensional models built up from the atomic coordinates of ConsA looked very similar. However, doking experiments of glucose and mannose in their monosaccharide-binding sites, by comparison with the ConA-mannose complex used as a model, reveled conformational changes in side chains of the animo acid residues invlved in the binding of monosaccharides. These results fully agree with crystallographic data showing that binding of specific ligands to ConsA requires conformational chances of this monosaccharide-binding site.
Subject(s)
Carbohydrates/biosynthesis , Models, Molecular , Plants, Medicinal/cytology , Lectins , Seeds/anatomy & histologyABSTRACT
Algunas de las especies vegetales conocidas comúnmente como muérdagos han sido utilizadas popularmente en México para tratar diversas afecciones entre las que figura el Cáncer. Con el propósito de investigar experimentalmente y en forma preliminar la posible acción antitumoral de las tres especies de muérdagos mexicanos: Cladocolea grahami, Phoradendron reichenbachianum y Phoradendron galeottii, en el presente trabajo se determinaron actividades citotóxicas de los extractos hexánicos y metanólicos de diferentes órganos (tallo, inflorescencia y hoja) de estas plantas, sobre cultivos de cuatro líneas celulares provenientes de cánceres humanos: OVCAR-5 (carcinoma de ovario), KB (carcinoma nasofaríngeo), UISO-SQC-1 (células escamosas de carcinoma de cérvix) y HCT-15 COLADCAR (carcinoma de colon), así como de una leucemia murina P388. Los resultados obtenidos se expresan como las dosis de los extractor vegetales que inhibieron el 50 por ciento del crecimiento celular respecto a cultivos control durante las fases de crecimiento celular exponencial (ED50); y muestran que las tres especies presentaron actividades en dos o más de los órganos analizados contra los cultivos OVCAR, P388 Y UISO; ninguna presentó actividad importante contra el cáncer de colon HCT-15 y sólo P. reichenbachianum fue activa contra las células KB